JP2021524247A5 - - Google Patents
Info
- Publication number
- JP2021524247A5 JP2021524247A5 JP2020565264A JP2020565264A JP2021524247A5 JP 2021524247 A5 JP2021524247 A5 JP 2021524247A5 JP 2020565264 A JP2020565264 A JP 2020565264A JP 2020565264 A JP2020565264 A JP 2020565264A JP 2021524247 A5 JP2021524247 A5 JP 2021524247A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- antigen
- nucleic acid
- vector
- optionally
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862675624P | 2018-05-23 | 2018-05-23 | |
| US62/675,624 | 2018-05-23 | ||
| PCT/US2019/033828 WO2019226939A1 (en) | 2018-05-23 | 2019-05-23 | Immune checkpoint inhibitor co-expression vectors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021524247A JP2021524247A (ja) | 2021-09-13 |
| JP2021524247A5 true JP2021524247A5 (https=) | 2022-05-27 |
Family
ID=68617211
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020565264A Withdrawn JP2021524247A (ja) | 2018-05-23 | 2019-05-23 | 免疫チェックポイント阻害剤の共発現ベクター |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20210213122A1 (https=) |
| EP (1) | EP3796930A4 (https=) |
| JP (1) | JP2021524247A (https=) |
| KR (1) | KR20210013589A (https=) |
| CN (1) | CN112351793A (https=) |
| AU (1) | AU2019275070A1 (https=) |
| CA (1) | CA3099642A1 (https=) |
| TW (1) | TW202000906A (https=) |
| WO (1) | WO2019226939A1 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4414990A3 (en) | 2013-01-17 | 2024-11-06 | Personalis, Inc. | Methods and systems for genetic analysis |
| US10125399B2 (en) | 2014-10-30 | 2018-11-13 | Personalis, Inc. | Methods for using mosaicism in nucleic acids sampled distal to their origin |
| US11299783B2 (en) | 2016-05-27 | 2022-04-12 | Personalis, Inc. | Methods and systems for genetic analysis |
| EP3634449A4 (en) | 2017-05-08 | 2021-03-17 | Gritstone Oncology, Inc. | ALPHAVIRUS NEOANTIGEN VECTORS |
| WO2020037302A1 (en) * | 2018-08-17 | 2020-02-20 | Gritstone Oncology, Inc. | Antigen-binding proteins targeting shared antigens |
| AU2019374874A1 (en) * | 2018-11-07 | 2021-06-10 | Gritstone Bio, Inc. | Alphavirus neoantigen vectors and interferon inhibitors |
| TWI852977B (zh) | 2019-01-10 | 2024-08-21 | 美商健生生物科技公司 | 前列腺新抗原及其用途 |
| MX2021014525A (es) | 2019-05-30 | 2022-03-17 | Gritstone Bio Inc | Adenovirus modificados. |
| JP7470787B2 (ja) | 2019-11-05 | 2024-04-18 | パーソナリス，インコーポレイティド | 単一試料からの腫瘍純度の推定 |
| CR20220220A (es) | 2019-11-18 | 2022-09-20 | Janssen Biotech Inc | Vacunas basadas en calr y jak2 mutantes y sus usos |
| EP4168569A4 (en) * | 2020-06-18 | 2024-08-07 | Personalis, Inc. | Machine-learning techniques for predicting surface-presenting peptides |
| EP4175664A2 (en) | 2020-07-06 | 2023-05-10 | Janssen Biotech, Inc. | Prostate neoantigens and their uses |
| CN116438308A (zh) | 2020-08-06 | 2023-07-14 | 磨石生物公司 | 多表位疫苗盒 |
| WO2022229966A1 (en) | 2021-04-29 | 2022-11-03 | Yeda Research And Development Co. Ltd. | T cell receptors directed against ras-derived recurrent neoantigens and methods of identifying same |
| WO2023034881A1 (en) * | 2021-09-02 | 2023-03-09 | Elixirgen Therapeutics, Inc. | Temperature-controllable, rna immunotherapeutic for cancer |
| WO2023059654A1 (en) | 2021-10-05 | 2023-04-13 | Personalis, Inc. | Customized assays for personalized cancer monitoring |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0803573A1 (en) * | 1996-04-25 | 1997-10-29 | Gesellschaft für Biotechnologische Forschung mbH (GBF) | Polycistronic expression construct with cytokines for multivalent vaccines |
| WO2002061113A2 (en) * | 2001-02-01 | 2002-08-08 | The Johns Hopkins University | Nucleic acid derived vaccine that encodes an antigen linked to a polypeptide that promotes antigen presentation |
| EP1434859A2 (en) * | 2001-07-25 | 2004-07-07 | New York University | Use of glycosylceramides as adjuvants for vaccines against infections and cancer |
| CA2500955A1 (en) * | 2002-10-03 | 2004-04-15 | Genencor International, Inc. | Optimized multi-epitope constructs and uses thereof |
| US9402888B2 (en) * | 2013-03-14 | 2016-08-02 | The Wistar Institute Of Anatomy And Biology | Methods and compositions for treating cancer |
| KR20230076867A (ko) * | 2013-12-20 | 2023-05-31 | 더 브로드 인스티튜트, 인코퍼레이티드 | 신생항원 백신과의 병용 요법 |
| CA2960096A1 (en) * | 2014-09-03 | 2016-03-10 | Bavarian Nordic A/S | Methods and compositions for enhancing immune responses |
| MX2018004544A (es) * | 2015-10-12 | 2018-11-09 | Nantomics Llc | Composiciones y métodos para los neoepítopos de cáncer viral. |
| CA3014466A1 (en) * | 2016-03-03 | 2017-09-08 | Cue Biopharma, Inc. | T-cell modulatory multimeric polypeptides and methods of use thereof |
| WO2017152042A2 (en) * | 2016-03-04 | 2017-09-08 | New York University | Virus vectors expressing multiple epitopes of tumor associated antigens for inducing antitumor immunity |
| EP3452082A1 (en) * | 2016-05-04 | 2019-03-13 | Fred Hutchinson Cancer Research Center | Cell-based neoantigen vaccines and uses thereof |
| JP2020500552A (ja) * | 2016-11-23 | 2020-01-16 | グリットストーン オンコロジー インコーポレイテッド | 新生抗原のウイルスによる送達方法 |
| WO2018161092A1 (en) * | 2017-03-03 | 2018-09-07 | New York University | Induction and enhancement of antitumor immunity involving virus vectors expressing multiple epitopes of tumor associated antigens and immune checkpoint inhibitors or proteins |
-
2019
- 2019-05-23 JP JP2020565264A patent/JP2021524247A/ja not_active Withdrawn
- 2019-05-23 US US17/058,113 patent/US20210213122A1/en not_active Abandoned
- 2019-05-23 CN CN201980044406.0A patent/CN112351793A/zh active Pending
- 2019-05-23 EP EP19808512.8A patent/EP3796930A4/en active Pending
- 2019-05-23 TW TW108117922A patent/TW202000906A/zh unknown
- 2019-05-23 CA CA3099642A patent/CA3099642A1/en active Pending
- 2019-05-23 WO PCT/US2019/033828 patent/WO2019226939A1/en not_active Ceased
- 2019-05-23 AU AU2019275070A patent/AU2019275070A1/en not_active Abandoned
- 2019-05-23 KR KR1020207036367A patent/KR20210013589A/ko not_active Ceased
-
2024
- 2024-01-04 US US18/404,681 patent/US20250025544A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021524247A5 (https=) | ||
| JP2022534282A5 (https=) | ||
| JP2021525076A5 (https=) | ||
| RU2019119272A (ru) | Вирусная доставка неоантигенов | |
| JP2022512912A5 (https=) | ||
| JP2023526495A5 (https=) | ||
| JP2023541108A5 (https=) | ||
| JP2021501572A5 (https=) | ||
| CN111328420B (zh) | 用于预防和治疗微卫星不稳定(msi)癌症的基于共有肿瘤新抗原的通用疫苗 | |
| JP2023523414A5 (https=) | ||
| JP2021524247A (ja) | 免疫チェックポイント阻害剤の共発現ベクター | |
| CN118576699A (zh) | Hbv疫苗 | |
| JP2022539417A5 (https=) | ||
| JP2023521662A5 (https=) | ||
| JP5148116B2 (ja) | 癌胎児性抗原融合タンパク質及びその使用 | |
| CN118414426A (zh) | 产生环状rna的单罐法 | |
| JP2023523413A5 (https=) | ||
| JP2004501646A5 (https=) | ||
| JP2005509420A5 (https=) | ||
| RU2019112725A (ru) | Композиции и способы для повышения стабильности трансгенов в поксвирусах | |
| EP4038222A1 (en) | Methods and compositions for identifying neoantigens for use in treating and preventing cancer | |
| CN115942942A (zh) | 感染性疾病抗原和疫苗 | |
| JP2024503108A5 (https=) | ||
| CN117587070A (zh) | 一种经遗传修饰的非人哺乳动物的制备方法及应用 | |
| US20070104685A1 (en) | Synthetic gene encoding human carcinoembryonic antigen and uses thereof |